Impact of Antithrombin Loss During Dialysis on Blood Clotting
Author Information
Author(s): Muacevic Alexander, Adler John R, Fujii Yoshinari, Nagaya Satomi, Seo Atsunobu, Kanazawa Yuji, Oba Taisei, Morishita Eriko
Primary Institution: Hokuriku University
Hypothesis
What are the mechanisms behind the reduction of antithrombin activity during hemodialysis?
Conclusion
Antithrombin activity and antigen levels decrease in patients on hemodialysis, likely due to long-term heparin use and dialysis-related leakage.
Supporting Evidence
- Antithrombin activity and antigen levels were significantly lower in patients on hemodialysis compared to healthy participants.
- Long-term heparin use was suggested as a contributing factor to decreased antithrombin levels.
- Antithrombin leakage was significantly greater with hemodiafiltration than with hemodialysis.
Takeaway
This study found that patients on dialysis lose an important protein that helps prevent blood clots, which can lead to serious health issues.
Methodology
Measured antithrombin activity and antigen levels before and after dialysis in 24 patients, and analyzed dialysis effluent for antithrombin levels.
Potential Biases
Potential bias due to the exclusion of patients who did not consent to participate.
Limitations
The sample size was small, limiting the analysis of the relationship between antithrombin leakage and activity.
Participant Demographics
Median age of participants was 70 years, with 14 men and 10 women.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website